Mitsubishi Electric ( MIELY ) Thursday said that it will begin sequentially shipping samples in late June of two types of new 5th-generation silicon carbide metal-oxide-semiconductor field-effect transistors (SiC-MOSFETs) in bare die form. The new SiC-MOSFETs are designed for use in inverters for drive motors and eAxles of electric vehicles, plug-in hybrid vehicles (PHEVs), and other electrified v...
Mitsubishi Electric ( MIELY ) Thursday said that it will begin sequentially shipping samples in late June of two types of new 5th-generation silicon carbide metal-oxide-semiconductor field-effect transistors (SiC-MOSFETs) in bare die form. The new SiC-MOSFETs are designed for use in inverters for drive motors and eAxles of electric vehicles, plug-in hybrid vehicles (PHEVs), and other electrified vehicles (xEVs). They feature Mitsubishi Electric’s proprietary trench structure and achieve industry-leading low on-resistance approximately 25% lower than that of existing products, the company said in a statement . Mitsubishi Electric’s 5th-generation SiC-MOSFET bare dies will contribute to the performance and miniaturization of xEV inverters and eAxles, which will extend the range and improve the power efficiency of xEVs. In addition, the company’s proprietary manufacturing process technology suppresses performance degradation and fluctuations in power loss and on-resistance, ensuring stable quality even after long-term use, and contributing to the durability and performance of xEV inverters and eAxles. More on Mitsubishi Electric Mitsubishi Electric Corporation (MIELY) Analyst/Investor Day - Slideshow Mitsubishi Electric to co-develop homegrown physical AI and robotics Mitsubishi Electric to ship new NX-type IGBT module samples Historical earnings data for Mitsubishi Electric Financial information for Mitsubishi Electric
Jade Biosciences ( JBIO ) has announced the pricing of a public offering of 10M shares of its common stock, priced at $15.00 per share, expected to raise gross proceeds of $150M from this offering. The offering will close on June 5, 2026, after meeting customary closing conditions. Additionally, there is a 30-day option for underwriters to purchase up to 1.5M extra shares at the same price. All sh...
Jade Biosciences ( JBIO ) has announced the pricing of a public offering of 10M shares of its common stock, priced at $15.00 per share, expected to raise gross proceeds of $150M from this offering. The offering will close on June 5, 2026, after meeting customary closing conditions. Additionally, there is a 30-day option for underwriters to purchase up to 1.5M extra shares at the same price. All shares are being sold directly by Jade. The company plans to use the funds from the offering, along with its existing cash and investments, to support clinical trials, preclinical studies, and manufacturing for its programs. This funding will also go toward research and development, capital expenditures, working capital, and other general corporate purposes. Jefferies, TD Cowen, and UBS Investment Bank are serving as joint book-running managers for the offering, while LifeSci Capital and BTIG are also involved in managing the offering. More on Jade Biosciences, Inc. Jade Biosciences: Strong Early Signal, But Still A Wait For Proof Jade Biosciences, Inc. (JBIO) Discusses Positive Interim Results From JADE101 Phase I Healthy Volunteer Study and Development Plans Transcript Jade Biosciences: Caution Advised Before Clinical Trial Results Jade Biosciences plans public offering, pre-funded warrants Seeking Alpha’s Quant Rating on Jade Biosciences, Inc.
The UK Competition and Markets Authority requires Google to let publishers opt out of AI-generated search summaries and training datasets. Google must provide clear attribution and links to publisher content within its AI search results. The ruling applies to Alphabet's (NasdaqGS:GOOGL) UK operations and includes testing new tools that give publishers more control. Alphabet, through Google Search,...
The UK Competition and Markets Authority requires Google to let publishers opt out of AI-generated search summaries and training datasets. Google must provide clear attribution and links to publisher content within its AI search results. The ruling applies to Alphabet's (NasdaqGS:GOOGL) UK operations and includes testing new tools that give publishers more control. Alphabet, through Google Search, is heavily involved in building AI-powered search features that blend traditional links with...
Wachiwit Netflix ( NFLX ) is using artificial intelligence to help viewers cut through content overload and find relevant titles more efficiently, according to Elizabeth Stone, the company’s Chief Product and Technology Officer. Speaking at the Bloomberg Tech conference in San Francisco on Wednesday, Stone said generative AI capabilities will enable “the more personalized, the more interactive, th...
Wachiwit Netflix ( NFLX ) is using artificial intelligence to help viewers cut through content overload and find relevant titles more efficiently, according to Elizabeth Stone, the company’s Chief Product and Technology Officer. Speaking at the Bloomberg Tech conference in San Francisco on Wednesday, Stone said generative AI capabilities will enable “the more personalized, the more interactive, the more immersive” experience of choosing what entertainment to consume. “That helps to solve a consumer frustration that’s brewing, which is, there’s so much content. How do I make sense of it, and what’s right for me, and what’s right for me in this moment?” Stone said. Netflix ( NFLX ) now integrates generative AI and natural language processing to help discern what a viewer is in the mood to watch, Stone said, as per the report. It is testing a voice user interface and other experiments that combine a person’s viewing preferences and history with other factors like what is trending, helping the platform make a highly tailored recommendation, she said. “That’s been a strength for Netflix for a long time, and I think it needs to continue to be a place where we’re state-of-the-art and continuing to innovate,” Stone added. More on Netflix Missing This Netflix Bottom Will Haunt Your Portfolio For Years (Upgrade) Netflix Is Still In A Bear Market And I Think The Market Is Wrong Netflix: Ad Empire Story Is Too Good To Ignore Hinde Group adds AMZN, NFLX; trims IBKR among Q1 moves Netflix continues losses for seven straight sessions
Cyriac Roeding, CEO and co-founder of cancer therapeutics startup Earli, gives his assessment of China's biotech developments, after predicting a decade ago that the country would become a main competitor to the US. He speaks with Yvonne Man on Bloomberg's The China Show." (Source: Bloomberg)
Cyriac Roeding, CEO and co-founder of cancer therapeutics startup Earli, gives his assessment of China's biotech developments, after predicting a decade ago that the country would become a main competitor to the US. He speaks with Yvonne Man on Bloomberg's The China Show." (Source: Bloomberg)